Information for the public

About infliximab

About infliximab

Infliximab is a type of immunosuppressant, which is given by injection. It stops inflammation by acting on a substance in the body called tumour necrosis factor (TNF) alpha.

Infliximab is licensed in the UK for treating severe flare-ups of the following diseases:

  • rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, in which the joints are inflamed

  • Crohn's disease and ulcerative colitis, in which the digestive system is inflamed

  • psoriasis, in which the skin is inflamed.

Infliximab is sometimes used to treat sarcoidosis but it isn't licensed in the UK for this. Use in this way is therefore off-label.